SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX]
COR 360.06+0.1%Feb 10 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DavidCG who wrote (673)11/8/1998 12:44:00 PM
From: John Lacelle  Read Replies (1) of 1255
 
David,

Actually, we know that. I think the
paranoia you sense is that based upon
the slide in the stock price, we think
that the clinical trials for the drug
"Ampalex" are not going well. I have
invested in small biotech drug stocks
over the years and my experience tells
me that there is current insider information
that is not good. Why else would we
have seen a slide from ~$2.50 a share
(a reasonable price for a risky stock)
to <$0.50 per share (by any name, a
penny-stock company in serious trouble).

Of course, this is only guesswork but my
instinct tells me that I am correct.

-John

BTW, There was an interesting article in
this mornings "Parade" magazine about new
drugs being used to treat Alzheimers disease.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News